Pol F. Boudes
Overview
Pol F. Boudes received an average of $893K in total compensation, including $456K in salary, at Galectin Therapeutics from 2020 to 2023. Pol Boudes also received an average of $1M at Amicus Therapeutics from 2009 to 2012.
- 2023
- 2022
- 2021
- 2020
- 2012
- 2011
- 2010
- 2009
Galectin TherapeuticsM.D., Former Chief Medical Officer
Galectin TherapeuticsM.D., Chief Medical Officer
Galectin TherapeuticsChief Medical Officer
Galectin TherapeuticsChief Medical Officer
Amicus TherapeuticsChief Medical Officer
Amicus TherapeuticsChief Medical Officer
Amicus TherapeuticsChief Medical Officer
Amicus TherapeuticsChief Medical Officer
Source: SEC filings on December 3, 2024, October 6, 2023, October 17, 2022, April 26, 2013, and April 27, 2012.
Related executives
We found 24 more executives who work or worked at Galectin Therapeutics and Amicus Therapeutics.
Joel Lewis
Galectin Therapeutics
Chief Executive Officer
Jack Callicutt
Galectin Therapeutics
Chief Financial Officer
Harold Shlevin
Galectin Therapeutics
Chief Executive Officer
Peter Traber
Galectin Therapeutics
Chief Executive Officer
James Czirr
Galectin Therapeutics
Chairman
John Crowley
Amicus Therapeutics
Chief Executive Officer
Bradley Campbell
Amicus Therapeutics
Chief Operating Officer
Jay Barth
Amicus Therapeutics